The stimulatory effect of hyperinsulinemia on both primary tumor growth and metastasis was demonstrated across a variety of breast cancer models employing different oncogenes (147–151) with tumors showing activation of the IR/IGF-1R and Akt (147). The gene discussed is IGF1R; the disease is hyperinsulinism.